Physician

Adolfo Carlos Fernandez-Obregon, M.D.

According to 2025 Medicare claims, Adolfo Fernandez-Obregon, M.D. (NPI: 1316944051) practices dermatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. Fernandez-Obregon uses personal NPI as billing NPI and primary practice location at 07030-2757.

Fernandez-Obregon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 271 traditional Medicare patients, billed 1,334 HCPCS/CPT codes, and received $93,776 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 966 prescription claims across 273 beneficiaries totaling $374,740 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 123 records totaling $84,838. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $216,703 to $374,740. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$72K$145K2015 Medicare payment: $112,502 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $144,673 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $123,550 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $121,773 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $128,171 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $110,420 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $143,038 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $121,909 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $103,191 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $93,776 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153591,887$112,502
20164172,440$144,673
20174212,053$123,550
20184302,019$121,773
20194091,905$128,171
20203161,581$110,420
20213611,869$143,038
20223541,754$121,909
20233161,658$103,191
20242711,334$93,776

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$247K$495K2015 Drug cost: $216,703 (USD; Tot_Drug_Cst)2016 Drug cost: $291,976 (USD; Tot_Drug_Cst)2017 Drug cost: $261,543 (USD; Tot_Drug_Cst)2018 Drug cost: $209,227 (USD; Tot_Drug_Cst)2019 Drug cost: $414,621 (USD; Tot_Drug_Cst)2020 Drug cost: $494,846 (USD; Tot_Drug_Cst)2021 Drug cost: $324,618 (USD; Tot_Drug_Cst)2022 Drug cost: $398,222 (USD; Tot_Drug_Cst)2023 Drug cost: $485,033 (USD; Tot_Drug_Cst)2024 Drug cost: $374,740 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015200617$216,703
2016238767$291,976
2017249883$261,543
2018256826$209,227
20193101,042$414,621
2020268914$494,846
20213381,132$324,618
20223031,170$398,222
20232931,062$485,033
2024273966$374,740

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths70112$107
11102Biopsy of related skin growth, first growth5157$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more208430$78
17000Destruction of precancer skin growth, 1 growth5892$60
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more6687$50

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab13390$82,583
KetoconazoleKetoconazole2517,517$3,200
Fluocinolone AcetonideFluocinolone Acetonide401,025$1,667
Triamcinolone AcetonideTriamcinolone Acetonide1995,334$1,513
Clobetasol PropionateClobetasol Propionate24589$1,416

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.105$8,485PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.18$76,353ABBVIE INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adolfo Carlos Fernandez-Obregon, M.D.?

Tedicare shows public-source Medicare data for Adolfo Carlos Fernandez-Obregon, M.D. (NPI 1316944051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adolfo Carlos Fernandez-Obregon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adolfo Carlos Fernandez-Obregon, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Adolfo Carlos Fernandez-Obregon, M.D. have Open Payments data?

Adolfo Carlos Fernandez-Obregon, M.D. has 123 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.